Hot Products
| Catalog No. | Information |
| CFN90863 | Cimicidanol 3-O-alpha-L-arabinoside Reference standards. |
| CFN70303 | Cimicifugic acid B Cimicifugic acid B shows inhibitory collagenolytic activity. |
| CFN70314 | Cimicifugic acid F Cimicifugic acid F has antioxidant activity. Cimicifugic acid F shows inhibition of neutrophil elastase activity with an IC50 of 18 mumol/L. It also shows strong hyaluronidase inhibitory activity. |
| CFN92973 | Cimicifugoside H1 Cimicifugoside H1 shows the protective function to cerebral neuron during cerebral ischemia. |
| CFN92972 | Cimicifugoside H2 Cimicifugoside H2 is a natural product from Cimicifuga foetida. |
| CFN99465 | Cimidahurinine Cimidahurinine can attenuate Doxorubicin (DOX)-induced cardiotoxicity in a dose-dependent manner with EC50 values of 45.79 uM; it protects against cardiotoxicity by decreasing reactive oxygen species (ROS) accumulation and downregulating apoptosis-related Bax/Bcl-2 proteins. |
| CFN98612 | Cimifugin Cimifugin evidently inhibits FITC-induced type 2 allergic contact dermatitis,and its mechanism might related to regulating the balance of Th1 /Th2 by inhibiting type 2 cytokines. Cimifugin displayed low to moderate inhibition towards AChE and BChE (3.12 and 21.63%, respectively) at 200 ug/mL. |
| CFN98340 | Cimigenoside |
| CFN98288 | Cimiracemoside C The Cimicifuga racemosa extract Ze 450 and some of its components (23-epi-26-deoxyactein, protopine and cimiracemoside C) can reduce significantly body weight, plasma glucose, improve glucose metabolism and insulin sensitivity in diabetic ob/ob mice; suggests that part of the effects may be related to AMPK activation.Ze 450 may have utility in the treatment of type 2 diabetes. |
| CFN90545 | Cineole Cineole has antihypertensive,and anti-inflammatory effects, it regulates nitric oxide and oxidative stress in rats chronically exposed to nicotine. Cineole can attenuate cerulein-induced AP via an anti-inflammatory mechanism and by combating oxidative stress, may can treat neurodegenerative disease. |
